A multicenter, randomized, double-blind, prospective, parallel study to compare the safety and efficacy of fenofibrate [Tricor] or ezetimibe as add-on therapy to atorvastatin in subjects with combined hyperlipidaemia [type V hyperlipoproteinaemia], typical of the metabolic syndrome
Phase of Trial: Phase III
Latest Information Update: 12 Oct 2007
At a glance
- Drugs Atorvastatin; Ezetimibe; Fenofibrate
- Indications Hyperlipidaemia
- Focus Therapeutic Use
- 12 Oct 2007 Status change from in progress to completed.
- 16 Nov 2005 New trial record.